Kleo Pharmaceuticals, Inc. — Form D/A
Kleo Pharmaceuticals, Inc. of NEW HAVEN, CT, a company, filed a Form D amendment with the SEC on 2017-05-26. $11.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-05-26
- Form: D/A
- Accession: 0001700389-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $11.0M
- Investors: 9
- Date of first sale: 2016-08-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-287320
Issuer
- Name: Kleo Pharmaceuticals, Inc.
- CIK: 0001700389
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 25 SCIENCE PARK, SUITE 2D, NEW HAVEN, CT, 06511
- Phone: 203-691-6332
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Declan Doogan | Director | Glasgow, X0 |
| David Spiegel | Director | Lewiston, ME |
| David Spiegel | Executive Officer | Lewiston, ME |
| Douglas Manion | Director | New Haven, CT |
| Douglas Manion | Executive Officer | New Haven, CT |
| Charles G Drake | Director | New York, NY |
| Roy Prieb | Director | New Haven, CT |
| Roy Prieb | Executive Officer | New Haven, CT |
| Alexander Goor | Director | New Haven, CT |
| Douglas G Manion | Executive Officer | New Haven, CT |
| John W Childs | Director | Houston, TX |
Other filings by this issuer (3)
More